CIP
EXAS

Champlain Investment Partners’s Exact Sciences EXAS Stock Holding History

Champlain Investment Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,352,745
Closed -$137M – 134
2025
Q4 		$137M Sell
1,352,745
-1,017,889
-43% -$81.7M 1.39% 16
2025
Q3 		$130M Sell
2,370,634
-159,186
-6% -$7.95M 0.98% 36
2025
Q2 		$134M Buy
2,529,820
+282,825
+13% +$14.4M 0.94% 41
2025
Q1 		$97.3M Sell
2,246,995
-190,310
-8% -$9.64M 0.7% 56
2024
Q4 		$137M Sell
2,437,305
-57,175
-2% -$3.56M 0.87% 42
2024
Q3 		$170M Buy
2,494,480
+245,980
+11% +$13.9M 1.03% 36
2024
Q2 		$95M Sell
2,248,500
-9,735
-0.4% -$536K 0.58% 70
2024
Q1 		$156M Buy
2,258,235
+1,438,010
+175% +$91M 0.89% 40
2023
Q4 		$60.7M Buy
+820,225
New +$53.8M 0.36% 96

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Champlain Investment Partners's EXAS Position: Q1 2026 in Review

Champlain Investment Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,352,745 shares — an estimated $137M sold.

Champlain Investment Partners first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $170M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Champlain Investment Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Champlain Investment Partners sold 1,352,745 Exact Sciences shares in Q1 2026, an estimated $137M.
  • Champlain Investment Partners first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
  • Champlain Investment Partners's Exact Sciences position peaked at $170M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.